INDmoney
Ptc Therapeutics, Inc. Stock Performance
as on March 6, 2026 at 6:13 am IST
Day's Low
Day's High
$62.21$64.50
0.50%
Downside
3.17%
Upside
52 Week's Low
52 Week's High
$35.95$87.5042.50%
Downside
39.96%
Upside
Ptc Therapeutics, Inc. share price movements today
- Previous Close
- $64.29
- Open
- $63.38
- Volume
- 649.9K
- Day's Low - High
- $62.21 - $64.50
- 52 Week Low - High
- $35.95 - $87.50
Ptc Therapeutics, Inc. Historical Returns
- 1 Month Return
- -11.15 %
- 3 Month Return
- -16.78 %
- 1 Year Return
- + 23.8 %
- 3 Year Return
- + 39.46 %
- 5 Year Return
- + 6.9 %
Ptc Therapeutics, Inc. Stock Fundamentals & Key Indicators
Check Ptc Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$5.3B
EPS (TTM)
-1.66
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
7.49
Industry PE ratio
8.111592920353983
PEG Ratio
0.81
EBITDA
895.3M
Revenue (TTM)
1.7B
Profit Margin
39.44%
Return On Equity TTM
-7740.12%
Ptc Therapeutics, Inc. Stock Valuation
Track how Ptc Therapeutics, Inc. P/E has moved over time to understand its valuation trends.
Ptc Therapeutics, Inc. in the last 5 years
Lowest (-10.19x)
December 31, 2024
Today (7.49x)
March 5, 2026
Industry (8.11x)
March 5, 2026
Highest (9.55x)
December 31, 2025
Today’s Price to Earnings Ratio: 7.49x
Ptc Therapeutics, Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Ptc Therapeutics, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $5.3B | 6.9% | 7.49 | 39.44% | |
| BUY | $120.5B | 125.44% | 30.96 | 32.94% | |
| BUY | $42.3B | 128.26% | 136.76 | 8.45% | |
| NA | $32.9B | NA | 560.45 | 5.37% | |
| BUY | $81.1B | 70.61% | 18.48 | 31.41% |
Stock Returns calculator for Ptc Therapeutics, Inc. Stock including INR - Dollar returns
The Ptc Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Ptc Therapeutics, Inc. investment value today
Current value as on today
₹1,25,765
Returns
₹25,765
(+25.77%)
Returns from Ptc Therapeutics, Inc. Stock
₹20,393 (+20.39%)
Dollar Returns*
₹5,372 (+5.37%)
Analyst Recommendation on Ptc Therapeutics, Inc. Stock
Based on 20 analysts
50.00%
Buy
30.00%
Hold
20.00%
Sell
Based on 20 analysts, 50% of analysts recommend a 'BUY' rating for Ptc Therapeutics, Inc.. Average target price of $87.57
Ptc Therapeutics, Inc. Share Price Target
Get share price movements and forecasts by analysts on Ptc Therapeutics, Inc..
What analysts predicted
28.61%UPSIDE
Target Price
$87.57
Current Price
$62.52
Analyzed by
20 Analysts
Target
$87.57
Ptc Therapeutics, Inc. target price $87.57, a slight upside of 28.61% compared to current price of $62.52. According to 20 analysts rating.
Ptc Therapeutics, Inc. Stock’s Investor Sentiment and Interest
Search interest for Ptc Therapeutics, Inc. Stock has increased by 50% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:50% versus previous 30 day period
Ptc Therapeutics, Inc. Quarterly Profit & Loss
All numbers in Millions USD
Ptc Therapeutics, Inc. Annual Profit & Loss
All numbers in Millions USD
Ptc Therapeutics, Inc. Quarterly Cash Flow
All numbers in Millions USD
Ptc Therapeutics, Inc. Annual Cash Flow
All numbers in Millions USD
Ptc Therapeutics, Inc. News & Key Events
Today's Timeline - 18 February
Wed, 03:51 PM
-PTC Therapeutics withdraws Translarna NDA, raising concerns about its rare disease pipeline and future regulatory strategy.
Wed, 11:31 PM
-PTC Therapeutics set to report earnings; analysts expect EPS of $-0.33 amid recent stock performance.
Insights on Ptc Therapeutics, Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 31.3% return, outperforming this stock by 7.5%
- NO EFFECT
Against Peers
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 61.6% return, outperforming this stock by 22.1%
NEGATIVE IMPACTPrice Dip
In the last 1 month, PTCT stock has moved down by -11.2%
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 211.00M → 164.67M (in $), with an average decrease of 22.0% per quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 15.89M → -134.96M (in $), with an average decrease of 949.1% per quarter
About Ptc Therapeutics, Inc.
| Organisation | Ptc Therapeutics, Inc. |
| Headquarters | 500 Warren Corporate Center Drive, Warren, NJ, United States, 07059 |
| Industry | Health Technology |
| CEO | Dr. Matthew B. Klein F.A.C.S., M.D., M.S. |
| E-voting on shares | Click here to vote |
Key Management of Ptc Therapeutics, Inc.
Name | Title |
|---|---|
Mr. Mark Elliott Boulding J.D. | Executive VP & Chief Legal Officer |
Dr. Matthew B. Klein F.A.C.S., M.D., M.S. | CEO & Director |
Dr. Allan Steven Jacobson Ph.D. | Co-Founder & Independent Director |
Mr. Eric Pauwels | Chief Business Officer |
Ms. Linda Montella Carter | Senior VP & Chief Information Officer |
Ms. Ellen Cavaleri | Head of Investor Relations |
Mr. Pierre Gravier M.S. | Chief Financial Officer |
Dr. Neil Almstead Ph.D. | Chief Technical Operations Officer |
Dr. Lee Scott Golden M.D., Ph.D. | Executive VP & Chief Medical Officer |
Ms. Christine Utter CPA | Senior VP, Chief Accounting Officer & Head of People Services |
FAQs
What is Ptc Therapeutics, Inc. share price today?
Ptc Therapeutics, Inc. share price today is $62.52 as on . Ptc Therapeutics, Inc. share today touched a day high of $64.5 and a low of $62.21.
What is the 52 week high and 52 week low for Ptc Therapeutics, Inc. share?
Ptc Therapeutics, Inc. share touched a 52 week high of $87.5 on and a 52 week low of $35.95 on . Ptc Therapeutics, Inc. stock price today i.e. is trending at $62.52,which is 28.55% down from its 52 week high and 73.91% up from its 52 week low.
What is Ptc Therapeutics, Inc.'s market capitalisation today?
Ptc Therapeutics, Inc. market capitalisation is $0.01T as on .
How to invest in Ptc Therapeutics, Inc. Stock (PTCT) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Ptc Therapeutics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Ptc Therapeutics, Inc. Shares that will get you 0.0240 shares as per Ptc Therapeutics, Inc. share price of $62.52 per share as on March 6, 2026 at 12:43 am IST.
What is the minimum amount required to buy Ptc Therapeutics, Inc. Stock (PTCT) from India?
Indian investors can start investing in Ptc Therapeutics, Inc. (PTCT) shares with as little as ₹91.558 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹915.58 in Ptc Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Ptc Therapeutics, Inc. share’s latest price of $62.52 as on March 6, 2026 at 12:43 am IST, you will get 0.1599 shares of Ptc Therapeutics, Inc.. Learn more about
fractional shares .
What are the returns that Ptc Therapeutics, Inc. has given to Indian investors in the last 5 years?
Ptc Therapeutics, Inc. stock has given 6.9% share price returns and 25.13% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?